Literature DB >> 11739690

Neutralizing human Fab fragments against measles virus recovered by phage display.

Cristina de Carvalho Nicacio1, R Anthony Williamson, Paul W H I Parren, Ake Lundkvist, Dennis R Burton, Ewa Björling.   

Abstract

Five human recombinant Fab fragments (Fabs) specific for measles virus (MV) proteins were isolated from three antibody phage display libraries generated from RNAs derived from bone marrow or splenic lymphocytes from three MV-immune individuals. All Fabs reacted in an enzyme-linked immunosorbent assay with MV antigens. In radioimmunoprecipitation assays two of the Fabs, MV12 and MT14, precipitated an approximately equal 80-kDa protein band corresponding to the hemagglutinin (H) protein from MV-infected Vero cell cultures, while two other Fabs, MT64 and GL29, precipitated an approximately equal 60-kDa protein corresponding the nucleocapsid (N) protein. In competition studies with MV fusion, H- and N protein-specific monoclonal antibodies (MAbs), the H-specific Fabs predominantly blocked the binding of H-specific MAbs, while the N-specific Fabs blocked MAbs to N. In addition, N-specific Fabs bound to denatured MV N protein in Western blotting. The specificity of the fifth Fab, MV4, could not be determined. By plaque reduction assays, three of the five Fabs, MV4, MV12, and MT14, exhibited neutralizing activity (80% cutoff) against MV (LEC-KI strain) at concentrations ranging between approximately 2 and 7 microg x ml(-1). Neutralization capacity against MV strains Edmonston and Schwarz was also detected, albeit at somewhat higher Fab concentrations. In conclusion, three neutralizing Fabs were isolated, two of them reactive against the H glycoprotein of MV and another reactive against an undefined epitope. This is the first study in which MV-neutralizing human recombinant Fab antibodies have been isolated from phage display libraries.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11739690      PMCID: PMC135717          DOI: 10.1128/jvi.76.1.251-258.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Human recombinant Puumala virus antibodies: cross-reaction with other hantaviruses and use in diagnostics.

Authors:  E M Salonen; P W Parren; Y F Graus; A Lundkvist; P Fisicaro; O Vapalahti; H Kallio-Kokko; A Vaheri; D R Burton
Journal:  J Gen Virol       Date:  1998-04       Impact factor: 3.891

2.  Characterization of epitopes on the measles virus hemagglutinin.

Authors:  H Sheshberadaran; E Norrby
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

3.  Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.

Authors:  T M Varsanyi; B Morein; A Löve; E Norrby
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies.

Authors:  D Ziegler; P Fournier; G A Berbers; H Steuer; K H Wiesmüller; B Fleckenstein; F Schneider; G Jung; C C King; C P Muller
Journal:  J Gen Virol       Date:  1996-10       Impact factor: 3.891

Review 5.  Measles vaccines, new developments and immunization strategies.

Authors:  T F Wild
Journal:  Vaccine       Date:  1999-03-26       Impact factor: 3.641

6.  Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain.

Authors:  M P Burgoon; R A Williamson; G P Owens; O Ghausi; R B Bastidas; D R Burton; D H Gilden
Journal:  J Neuroimmunol       Date:  1999-02-01       Impact factor: 3.478

7.  Human neutralizing human immunodeficiency virus type 2-specific Fab molecules generated by phage display.

Authors:  Ewa Björling; Eva von Garrelts; Andreas Mörner; Mariethe Ehnlund; Mats A A Persson
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

8.  Recombinant human monoclonal antibodies to Ebola virus.

Authors:  T Maruyama; P W Parren; A Sanchez; I Rensink; L L Rodriguez; A S Khan; C J Peters; D R Burton
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

9.  Immunization of mice with plasmid DNA expressing the measles virus nucleoprotein gene.

Authors:  A R Fooks; D Jeevarajah; A Warnes; G W Wilkinson; J C Clegg
Journal:  Viral Immunol       Date:  1996       Impact factor: 2.257

10.  Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein.

Authors:  R Drillien; D Spehner; A Kirn; P Giraudon; R Buckland; F Wild; J P Lecocq
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

View more
  14 in total

1.  Isolation of human monoclonal antibodies that neutralize human rotavirus.

Authors:  Kyoko Higo-Moriguchi; Yasushi Akahori; Yoshitaka Iba; Yoshikazu Kurosawa; Koki Taniguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo.

Authors:  John V Williams; Zhifeng Chen; Gabriella Cseke; David W Wright; Christopher J Keefer; Sharon J Tollefson; Ann Hessell; Amy Podsiad; Bryan E Shepherd; Pietro Paolo Sanna; Dennis R Burton; James E Crowe; R Anthony Williamson
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

Review 3.  Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy.

Authors:  Kristian Daniel Ralph Roth; Esther Veronika Wenzel; Maximilian Ruschig; Stephan Steinke; Nora Langreder; Philip Alexander Heine; Kai-Thomas Schneider; Rico Ballmann; Viola Fühner; Philipp Kuhn; Thomas Schirrmann; André Frenzel; Stefan Dübel; Maren Schubert; Gustavo Marçal Schmidt Garcia Moreira; Federico Bertoglio; Giulio Russo; Michael Hust
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

4.  The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.

Authors:  Ann R Hunt; Shana Frederickson; Toshiaki Maruyama; John T Roehrig; Carol D Blair
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13

5.  Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential.

Authors:  Philipp Diebolder; Armin Keller; Stephanie Haase; Anne Schlegelmilch; Jonathan D Kiefer; Tamana Karimi; Tobias Weber; Gerhard Moldenhauer; Roland Kehm; Anna M Eis-Hübinger; Dirk Jäger; Philippe A Federspil; Christel Herold-Mende; Gerhard Dyckhoff; Roland E Kontermann; Michaela A E Arndt; Jürgen Krauss
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

Review 6.  High affinity, developability and functional size: the holy grail of combinatorial antibody library generation.

Authors:  Dirk Ponsel; Julia Neugebauer; Kathrin Ladetzki-Baehs; Kathrin Tissot
Journal:  Molecules       Date:  2011-05-03       Impact factor: 4.411

7.  Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.

Authors:  Patrycja J Lech; Gregory J Tobin; Ruth Bushnell; Emily Gutschenritter; Linh D Pham; Rebecca Nace; Els Verhoeyen; François-Loïc Cosset; Claude P Muller; Stephen J Russell; Peter L Nara
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

8.  Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV).

Authors:  Martina Inga Kirsch; Birgit Hülseweh; Christoph Nacke; Torsten Rülker; Thomas Schirrmann; Hans-Jürgen Marschall; Michael Hust; Stefan Dübel
Journal:  BMC Biotechnol       Date:  2008-09-02       Impact factor: 2.563

Review 9.  Infectious disease antibodies for biomedical applications: A mini review of immune antibody phage library repertoire.

Authors:  Jing Yi Lai; Theam Soon Lim
Journal:  Int J Biol Macromol       Date:  2020-07-08       Impact factor: 6.953

Review 10.  Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.

Authors:  Philipp Kuhn; Viola Fühner; Tobias Unkauf; Gustavo Marcal Schmidt Garcia Moreira; André Frenzel; Sebastian Miethe; Michael Hust
Journal:  Proteomics Clin Appl       Date:  2016-06-21       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.